Toward defining the autoimmune microbiome for type 1 diabetes
Adriana Giongo(University of Florida), Eric W. Triplett(University of Florida), Heikki Hyöty(Tampere University of Applied Sciences), David B. Crabb(University of Florida), Luis Leon Novelo(University of Florida), Desmond Schatz(University of Florida), Jennifer C. Drew(University of Florida), Mark A. Atkinson(University of Florida), Nabanita Mukherjee(AbbVie (United States)), Jorma Ilonen(University of Turku), K.A. Gano(University of Florida), Josef Neu(University of Florida), George Casella(University of Chicago), Clive Wasserfall(University of Florida), Olli Simell(Turku University Hospital), Mikael Knip(Åbo Akademi University), Tuula Simell(Turku University Hospital), Riitta Veijola(Diabetes Tutkimussaatio)
Cited by 814
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Type 1 diabetes
|The Lancet|2013|2.7k
Pyrosequencing enumerates and contrasts soil microbial diversity
|The ISME Journal|2007|1.9k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k